Wolfson Institute of Preventive Medicine - Barts and The London

European randomised trial of screening for prostate cancer

Centre of Cancer Prevention

Project Investigator:  Professor Sue Moss

Overview

The ongoing European randomised trial of screening for prostate cancer (ERSPC) involves centres in eight countries.

It is one of only two randomised trials worldwide examining the effect of routine screening by PSA testing on mortality from prostate cancer, and has recruited over 160,000 men in the core age-group, 55-69 at entry.

The central database for this study is held in the Centre for Cancer Prevention; data are obtained from all centres at regular intervals, and analyses and reports produced for the Data Monitoring and Scientific Committees.

Staff

  • Professor Sue Moss
  • Mary Neville

Contact

Mary Neville
Email: m.neville@qmul.ac.uk
Phone: +44 (0) 20 7882 3493